WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for KYMR

Based on 21 analysts offering 12 month price targets for Kymera Therapeutics Inc

Min Forecast
$100.00+26.76%
Avg Forecast
$120.33+52.53%
Max Forecast
$140.00+77.46%

Should I buy or sell KYMR stock?

Based on 21 analysts offering ratings for Kymera Therapeutics Inc.

Strong Buy
Strong Buy
17 analysts 80.95%
Buy
4 analysts 19.05%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although KYMR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates KYMR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their KYMR stock forecasts and price targets.

KYMR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-06
lockedlocked$00.00+00.00%2026-03-16
lockedlocked$00.00+00.00%2026-03-03
lockedlocked$00.00+00.00%2026-03-02
lockedlocked$00.00+00.00%2026-03-02Find Out Why
BTIG
Top 32%
69
Strong BuyMaintains$134.00+66.23%2026-02-26
Piper Sandler
Bottom 9%
9
Strong BuyMaintains$140.00+73.68%2026-02-26
Barclays
Top 16%
85
Strong BuyMaintains$133.00+64.99%2026-01-28Find out why
B. Riley Securities
Top 27%
74
Strong BuyMaintains$117.00+45.14%2025-12-22
RBC Capital
Top 13%
88
BuyMaintains$103.00+27.78%2025-12-16

1 of 3

Forecast return on equity

Is KYMR forecast to generate an efficient return?

Company
-22.45%
Industry
85.8%
Market
169.74%
KYMR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is KYMR forecast to generate an efficient return on assets?

Company
-20.71%
Industry
29.42%
KYMR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KYMR earnings per share forecast

What is KYMR's earnings per share in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
-$3.47
Avg 2 year Forecast
-$4.30
Avg 3 year Forecast
-$4.42

KYMR revenue forecast

What is KYMR's revenue in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$92.1M+79.01%
Avg 2 year Forecast
$39.3M-23.64%
Avg 3 year Forecast
$38.0M-26.23%
KYMR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

KYMR revenue growth forecast

How is KYMR forecast to perform vs Biotechnology companies and vs the US market?

Company
-18.1%
Industry
36.05%
Market
13.75%
KYMR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
KYMR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

KYMR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KYMR$80.61$120.33+49.28%Strong Buy
PTGX$102.01$115.17+12.90%Strong Buy
SYRE$74.32$89.08+19.86%Strong Buy
PCVX$47.39$105.00+121.57%Strong Buy
CORT$59.69$86.25+44.50%Strong Buy
View Top Biotech Stocks

Kymera Therapeutics Stock Forecast FAQ

Is Kymera Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 21 Wall Street analysts covering (NASDAQ: KYMR) stock is to Strong Buy KYMR stock.

Out of 21 analysts, 17 (80.95%) are recommending KYMR as a Strong Buy, 4 (19.05%) are recommending KYMR as a Buy, 0 (0%) are recommending KYMR as a Hold, 0 (0%) are recommending KYMR as a Sell, and 0 (0%) are recommending KYMR as a Strong Sell.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.

What is KYMR's earnings growth forecast for 2026-2028?

(NASDAQ: KYMR) Kymera Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.38%.

Kymera Therapeutics's earnings in 2026 is -$315,004,000.On average, 24 Wall Street analysts forecast KYMR's earnings for 2026 to be -$285,672,377, with the lowest KYMR earnings forecast at -$330,510,989, and the highest KYMR earnings forecast at -$232,336,557. On average, 23 Wall Street analysts forecast KYMR's earnings for 2027 to be -$353,329,243, with the lowest KYMR earnings forecast at -$421,767,557, and the highest KYMR earnings forecast at -$277,249,200.

In 2028, KYMR is forecast to generate -$363,356,443 in earnings, with the lowest earnings forecast at -$518,337,965 and the highest earnings forecast at -$256,520,288.

What is KYMR's revenue growth forecast for 2026-2028?

(NASDAQ: KYMR) Kymera Therapeutics's forecast annual revenue growth rate of -18.1% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.75%.

Kymera Therapeutics's revenue in 2026 is $51,475,000.On average, 24 Wall Street analysts forecast KYMR's revenue for 2026 to be $7,579,625,446, with the lowest KYMR revenue forecast at $3,951,160,982, and the highest KYMR revenue forecast at $11,141,790,295. On average, 23 Wall Street analysts forecast KYMR's revenue for 2027 to be $3,233,299,012, with the lowest KYMR revenue forecast at -$1,047,961,671, and the highest KYMR revenue forecast at $8,416,596,404.

In 2028, KYMR is forecast to generate $3,123,731,904 in revenue, with the lowest revenue forecast at -$2,015,310,906 and the highest revenue forecast at $6,477,785,055.

What is KYMR's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: KYMR) forecast ROA is -20.71%, which is lower than the forecast US Biotechnology industry average of 29.42%.

What is KYMR's Price Target?

According to 21 Wall Street analysts that have issued a 1 year KYMR price target, the average KYMR price target is $120.33, with the highest KYMR stock price forecast at $140.00 and the lowest KYMR stock price forecast at $100.00.

On average, Wall Street analysts predict that Kymera Therapeutics's share price could reach $120.33 by May 6, 2027. The average Kymera Therapeutics stock price prediction forecasts a potential upside of 49.28% from the current KYMR share price of $80.61.

What is KYMR's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: KYMR) Kymera Therapeutics's current Earnings Per Share (EPS) is -$3.58. On average, analysts forecast that KYMR's EPS will be -$3.47 for 2026, with the lowest EPS forecast at -$4.02, and the highest EPS forecast at -$2.82. On average, analysts forecast that KYMR's EPS will be -$4.30 for 2027, with the lowest EPS forecast at -$5.13, and the highest EPS forecast at -$3.37. In 2028, KYMR's EPS is forecast to hit -$4.42 (min: -$6.30, max: -$3.12).

What is KYMR's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: KYMR) forecast ROE is -22.45%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.